Culture is still pharma’s biggest transformation bottleneck – what does it take to move from project thinking to product thinking?
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why An eTMF? It's Time For A Specialized Digital Solution
Clinical trials generate reams of documents. Use an electronic trial master file to streamline much of the work of document management, logging, and compliance.
-
Using IRT Data To Automate And Optimize Clinical Supply
Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
Why Scalable EDC Systems Matter In Global Pharmaceutical Trials
Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.
-
The Impact Of RWD And Cloud Tech On Research, Health Outcomes
Far too often, valuable data sources are siloed, disparate, and unusable. Learn how expansive datasets can empower the industry to advance clinical trials and outcomes research, benefiting all communities.
-
Fear Isn't A Strategy: Rethinking AI In Clinical Trials
As AI restrictions rise, needed oversight is slowing trials. This piece explores how delays hurt patients and how sites and sponsors can modernize without sacrificing regulatory trust.
-
AI-Powered Breakthroughs In CNS And Pain Trials
Discover how AI-powered tools like EEG are revolutionizing neurological and pain clinical trials by replacing subjectivity with precision and drastically accelerating the path to approval.
-
How SaaS Unlocks New Possibilities For Life Science Organizations
The rise of SaaS (software-as-a-service) has transformed industries, including life sciences, by enabling new possibilities. See how it’s already helping life science organizations around the world today.
-
One Day, Clinical Trials Will Represent The Real World
What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
AI In Clinical Trials: Key Insights From Industry Experts
Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.
-
Your CRAs Aren't Monitoring. They're Managing Workarounds.
CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.
RECENT NEWSLETTERS
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights